Pages that link to "Q59277539"

The following pages link to The DRD2 TaqI-B polymorphism and its relationship to smoking abstinence and withdrawal symptoms (Q59277539):

Displaying 20 items.

• A review of pharmacogenetic studies of substance-related disorders (Q27312296) (← links)
• Nicotine withdrawal (Q30404700) (← links)
• Common and unique biological pathways associated with smoking initiation/progression, nicotine dependence, and smoking cessation (Q30435362) (← links)
• Association of the DRD2 gene Taq1A polymorphism and smoking behavior: a meta-analysis and new data (Q33412991) (← links)
• Sex heterogeneity in pharmacogenetic smoking cessation clinical trials (Q33605769) (← links)
• Pharmacogenetics of antidepressant response (Q34155796) (← links)
• Genetic linkage findings for DSM-IV nicotine withdrawal in two populations (Q34373128) (← links)
• Suicidal behavior and haplotypes of the dopamine receptor gene (DRD2) and ANKK1 gene polymorphisms in patients with alcohol dependence--preliminary report (Q34557033) (← links)
• Nicotine withdrawal sensitivity, linkage to chr6q26, and association of OPRM1 SNPs in the SMOking in FAMilies (SMOFAM) sample (Q34614468) (← links)
• NCAM1-TTC12-ANKK1-DRD2 variants and smoking motives as intermediate phenotypes for nicotine dependence (Q35181211) (← links)
• The aggregate effect of dopamine genes on dependence symptoms among cocaine users: cross-validation of a candidate system scoring approach (Q36154550) (← links)
• An initial investigation of associations between dopamine-linked genetic variation and smoking motives in African Americans (Q36255624) (← links)
• The D2 dopamine receptor gene and nicotine dependence among bladder cancer patients and controls (Q37037238) (← links)
• The CHRNA3 rs578776 Variant is Associated with an Intrinsic Reward Sensitivity Deficit in Smokers (Q37189885) (← links)
• Relationship among methadone dose, polymorphisms of dopamine D2 receptor and tri-dimensional personality questionnaire in heroin-addicted patients (Q37223916) (← links)
• The impact of genetic variation in DRD2 and SLC6A3 on smoking cessation in a cohort of participants 1 year after enrollment in a lung cancer screening study (Q37313968) (← links)
• Dopamine D2 receptor gene polymorphisms and response to cabergoline therapy in patients with prolactin-secreting pituitary adenomas (Q46708438) (← links)
• The dopamine D2 receptor mediates approach-avoidance tendencies in smokers (Q47761117) (← links)
• Analysis of Dopamine D2 Receptor (DRD2) Gene Polymorphisms in Cannabinoid Addicts* (Q52300747) (← links)
• Personality Traits or Genetic Determinants-Which Strongly Influences E-Cigarette Users? (Q92705761) (← links)